# HER2 Positive CTC in Advanced Gastric Cancer

> **NCT01847794** · NA · UNKNOWN · sponsor: **Peking University** · enrollment: 50 (estimated)

## Conditions studied

- HER2 Positive Advanced Gastric Cancer

## Interventions

- **DEVICE:** Cell Search® CTC epithelial kit

## Key facts

- **NCT ID:** NCT01847794
- **Lead sponsor:** Peking University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-06
- **Primary completion:** 2015-06
- **Final completion:** 2016-06
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2013-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01847794

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01847794, "HER2 Positive CTC in Advanced Gastric Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01847794. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
